Cisapride monohydrate, >=98% (HPLC), solid

Biochem/physiol Actions

5-HT4 serotonin receptor agonist.

Features and Benefits

This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

10, 50 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Form Assay Price Quantity
3573316 Cisapride monohydrate, >=98% (HPLC), solid white 100 QBYYXIDJOFZORM-IKGOIYPNSA-N 1S/C23H29ClFN3O4.H2O/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16;/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(
£189.43 (exc VAT) per 10MG
-
+
3573317 Cisapride monohydrate, >=98% (HPLC), solid white 100 QBYYXIDJOFZORM-IKGOIYPNSA-N 1S/C23H29ClFN3O4.H2O/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16;/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(
£722.89 (exc VAT) per 50MG
-
+